A network for sharing data and resources in immuno-oncology
Immuno-Oncology Translation Network: Data Management and Resource-Sharing Center at RPCI
This study is all about finding better ways to treat cancer using the body's immune system by working together with different experts to share information, which could lead to new treatments and help patients like you have more effective options.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Roswell Park Cancer Institute Corp NIH-funded |
| Lab location | 1 site (Buffalo, United States) |
| Project ID | NIH-9625289 on NIH RePORTER |
What this research studies
This research focuses on enhancing the effectiveness of immuno-oncology treatments for cancer by creating a collaborative network that shares data and resources. It aims to identify new immune targets, understand resistance mechanisms, and evaluate combination therapies through a multi-disciplinary approach. Patients may benefit from improved treatment strategies and preventive measures against cancer as the research progresses. The project will also streamline data collection and management to support ongoing cancer studies.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 21 and older who are undergoing treatment for cancer or are at risk of developing cancer.
Not a fit: Patients with non-malignant conditions or those under 21 years old may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective cancer treatments and preventive strategies for patients.
How similar studies have performed: Previous research in immuno-oncology has shown promising results, indicating that collaborative approaches can lead to significant advancements in cancer treatment.
Where this research is happening
Buffalo, United States
- Roswell Park Cancer Institute Corp — Buffalo, United States (Active)
Researchers
- Principal investigator: Hutson, Alan David — Roswell Park Cancer Institute Corp
- Study coordinator: Hutson, Alan David
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.